This week, 5 Health Care Equipment & Supplies stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Alere Inc. (ALR) declines this week from a C to a D. Alere Inc. develops and manufactures patient diagnosis, monitoring, and health management products and services for cardiology, infectious diseases, toxicology, diabetes, oncology, and womens health in the United States and internationally. For more information, get Portfolio Grader’s complete analysis of ALR stock.
CryoLife, Inc. (CRY) gets weaker ratings this week as last week’s C drops to a D. CryoLife, Inc. preserves and distributes human tissues in addition to developing, manufacturing, and commercializing medical devices for cardiac and vascular transplant applications. The company also gets F’s in operating margin growth. For more information, get Portfolio Grader’s complete analysis of CRY stock.
Slipping from a C to a D rating, Tandem Diabetes Care, Inc. (TNDM) takes a hit this week. The company also gets F’s in earnings surprise, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of TNDM stock.
This week, Neovasc Inc. (NVCN) drops from a C to a D rating. The company also gets F’s in sales growth, earnings revisions, and return on equity. For more information, get Portfolio Grader’s complete analysis of NVCN stock.
Bovie Medical Corporation (BVX) experiences a ratings drop this week, going from last week’s C to a D. Bovie Medical Corporation develops, manufactures, and markets medical products and devices with an emphasis on electrosurgical generators and electrosurgical disposables in the United States, Canada, and internationally. The company also gets F’s in free cash flow. For more information, get Portfolio Grader’s complete analysis of BVX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.